Amygdala, neuropeptides, and chronic pain-related affective behaviors.


Journal

Neuropharmacology
ISSN: 1873-7064
Titre abrégé: Neuropharmacology
Pays: England
ID NLM: 0236217

Informations de publication

Date de publication:
15 06 2020
Historique:
received: 03 12 2019
revised: 04 03 2020
accepted: 11 03 2020
pubmed: 20 3 2020
medline: 4 6 2021
entrez: 20 3 2020
Statut: ppublish

Résumé

Neuropeptides play important modulatory roles throughout the nervous system, functioning as direct effectors or as interacting partners with other neuropeptide and neurotransmitter systems. Limbic brain areas involved in learning, memory and emotions are particularly rich in neuropeptides. This review will focus on the amygdala, a limbic region that plays a key role in emotional-affective behaviors and pain modulation. The amygdala is comprised of different nuclei; the basolateral (BLA) and central (CeA) nuclei and in between, the intercalated cells (ITC), have been linked to pain-related functions. A wide range of neuropeptides are found in the amygdala, particularly in the CeA, but this review will discuss those neuropeptides that have been explored for their role in pain modulation. Calcitonin gene-related peptide (CGRP) is a key peptide in the afferent nociceptive pathway from the parabrachial area and mediates excitatory drive of CeA neurons. CeA neurons containing corticotropin releasing factor (CRF) and/or somatostatin (SOM) are a source of long-range projections and serve major output functions, but CRF also acts locally to excite neurons in the CeA and BLA. Neuropeptide S (NPS) is associated with inhibitory ITC neurons that gate amygdala output. Oxytocin and vasopressin exert opposite (inhibitory and excitatory, respectively) effects on amygdala output. The opioid system of mu, delta and kappa receptors (MOR, DOR, KOR) and their peptide ligands (β-endorphin, enkephalin, dynorphin) have complex and partially opposing effects on amygdala function. Neuropeptides therefore serve as valuable targets to regulate amygdala function in pain conditions. This article is part of the special issue on Neuropeptides.

Identifiants

pubmed: 32188569
pii: S0028-3908(20)30118-0
doi: 10.1016/j.neuropharm.2020.108052
pmc: PMC7214122
mid: NIHMS1578766
pii:
doi:

Substances chimiques

AVP protein, human 0
Neuropeptides 0
Neurophysins 0
Protein Precursors 0
neuropeptide S, human 0
Vasopressins 11000-17-2
Oxytocin 50-56-6
Corticotropin-Releasing Hormone 9015-71-8

Types de publication

Journal Article Research Support, N.I.H., Extramural Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

108052

Subventions

Organisme : NIAAA NIH HHS
ID : R01 AA027096
Pays : United States
Organisme : NIDA NIH HHS
ID : P01 DA041307
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS109255
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS106902
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS038261
Pays : United States
Organisme : NIDA NIH HHS
ID : R01 DA041809
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Ltd. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of competing interest There are no conflicts of interest.

Références

Science. 2005 Apr 8;308(5719):245-8
pubmed: 15821089
Addict Biol. 2015 Jan;20(1):56-68
pubmed: 23869743
Front Endocrinol (Lausanne). 2017 Dec 22;8:356
pubmed: 29312146
Neuroscience. 2011 Jan 13;172:153-63
pubmed: 20950671
Mol Pain. 2010 Feb 08;6:10
pubmed: 20144185
J Neurophysiol. 2009 Oct;102(4):2253-64
pubmed: 19625541
Neuron. 2012 Oct 4;76(1):142-59
pubmed: 23040812
Annu Rev Neurosci. 2018 Jul 8;41:453-473
pubmed: 29852083
J Neurosci. 2019 Feb 6;39(6):1030-1043
pubmed: 30530860
Cell. 2015 Jul 16;162(2):363-374
pubmed: 26186190
J Comp Neurol. 1991 Jun 8;308(2):293-310
pubmed: 1890240
Neuroscience. 2003;120(3):677-94
pubmed: 12895509
Brain Res Mol Brain Res. 1998 Jun 1;57(1):149-54
pubmed: 9630585
Biochim Biophys Acta. 2005 Apr 15;1722(3):235-46
pubmed: 15777626
Neuron. 2017 Jan 04;93(1):147-163
pubmed: 28056342
J Neurosci. 2004 Mar 24;24(12):3031-9
pubmed: 15044542
Neuron. 2004 Aug 19;43(4):487-97
pubmed: 15312648
Brain Res. 1996 Nov 25;741(1-2):13-26
pubmed: 9001699
Prog Brain Res. 1996;107:243-55
pubmed: 8782523
Trends Neurosci. 2012 Nov;35(11):649-59
pubmed: 22974560
Brain Res. 1978 Sep 15;153(1):211-6
pubmed: 679048
Neuroscience. 2002;115(2):455-62
pubmed: 12421611
Adv Exp Med Biol. 2018;1099:157-166
pubmed: 30306523
Neuron. 2008 Jul 31;59(2):298-310
pubmed: 18667157
Brain Res. 2010 Feb 16;1314:44-55
pubmed: 19716811
Peptides. 1992 May-Jun;13(3):451-60
pubmed: 1381826
Neuron. 2019 May 8;102(3):564-573.e6
pubmed: 30878290
Brain Res. 1994 Jun 20;648(2):215-21
pubmed: 7922536
Brain Res. 1984 Jul 23;306(1-2):354-8
pubmed: 6087978
Physiol Behav. 2006 Jun 15;88(1-2):67-76
pubmed: 16647726
Peptides. 2010 Dec;31(12):2259-63
pubmed: 20800637
J Psychiatr Res. 2000 May-Jun;34(3):171-81
pubmed: 10867111
Brain Res Bull. 2001 Jan 1;54(1):55-63
pubmed: 11226714
Nat Commun. 2019 Mar 18;10(1):1238
pubmed: 30886240
Neuron. 2012 Feb 9;73(3):553-66
pubmed: 22325206
Life Sci. 2015 Jan 1;120:8-12
pubmed: 25447449
J Comp Neurol. 1987 Aug 15;262(3):365-74
pubmed: 3655018
Exp Brain Res. 1989;77(1):217-20
pubmed: 2792265
Nat Neurosci. 2014 Oct;17(10):1304-12
pubmed: 25254980
Physiol Rev. 2012 Oct;92(4):1813-64
pubmed: 23073632
J Neurosci. 2016 Jan 20;36(3):837-50
pubmed: 26791214
Biol Psychiatry. 2020 Jan 1;87(1):54-63
pubmed: 31521334
Brain Res. 1993 May 28;612(1-2):151-5
pubmed: 8101129
Dev Neurobiol. 2007 Feb 15;67(3):326-38
pubmed: 17443791
Annu Rev Neurosci. 2015 Jul 8;38:369-88
pubmed: 26154981
J Neuroendocrinol. 2012 Apr;24(4):609-28
pubmed: 22375852
Eur J Pharmacol. 2008 Apr 7;583(2-3):226-42
pubmed: 18275951
J Comp Neurol. 2007 Jan 1;500(1):84-102
pubmed: 17099900
Pain. 2015 Oct;156(10):2032-41
pubmed: 26098442
Brain Struct Funct. 2015 Jan;220(1):541-58
pubmed: 24271021
Pain. 2007 Jan;127(1-2):161-72
pubmed: 17055162
J Neurosci. 2008 Apr 9;28(15):3861-76
pubmed: 18400885
J Comp Neurol. 2005 Aug 15;489(1):92-119
pubmed: 15977170
Neuroscience. 2009 Mar 17;159(2):526-39
pubmed: 19166913
J Neurophysiol. 2013 Oct;110(8):1765-81
pubmed: 23883857
Neuroscience. 2003;118(4):1015-22
pubmed: 12732246
Pain. 2015 Apr;156 Suppl 1:S24-31
pubmed: 25789433
Exp Physiol. 1997 Mar;82(2):273-81
pubmed: 9129941
Eur J Pain. 2012 Jan;16(1):61-71
pubmed: 21684787
Neuroscience. 2012 Apr 5;207:218-26
pubmed: 22300983
Front Neuroendocrinol. 2015 Jan;36:49-71
pubmed: 25102443
Eur J Pharmacol. 2019 Sep 15;859:172557
pubmed: 31326375
Brain Res. 1993 May 28;612(1-2):253-7
pubmed: 8330203
Brain Res Bull. 1994;33(5):529-34
pubmed: 8186998
Nature. 1982 Jul 15;298(5871):240-4
pubmed: 6283379
J Neurosci. 2005 Nov 16;25(46):10717-28
pubmed: 16291945
J Comp Neurol. 1988 Apr 15;270(3):416-26, 398-9
pubmed: 2836477
Neuroscience. 2005;133(1):97-103
pubmed: 15893634
J Comp Neurol. 2007 Nov 20;505(3):268-91
pubmed: 17879271
Nature. 2017 Feb 2;542(7639):96-100
pubmed: 28117439
Pain. 1995 Nov;63(2):141-52
pubmed: 8628579
Front Med (Lausanne). 2015 Mar 24;2:19
pubmed: 25853137
J Neurosci. 2019 May 22;39(21):4162-4178
pubmed: 30862664
Pain. 2018 May;159(5):919-928
pubmed: 29369967
Pain. 2000 Jan;84(1):1-12
pubmed: 10601667
Curr Opin Neurobiol. 2014 Dec;29:187-93
pubmed: 25463629
Physiol Rev. 2010 Apr;90(2):419-63
pubmed: 20393190
Brain Res. 2009 Oct 13;1293:61-75
pubmed: 19332030
Neuroscience. 1999;92(1):281-91
pubmed: 10392850
Neurosci Lett. 2010 May 3;474(3):154-157
pubmed: 20298749
Neuroscience. 2002;112(3):605-17
pubmed: 12074902
Neuropsychopharmacology. 2012 Jan;37(1):308-9
pubmed: 22157874
eNeuro. 2019 Jun 18;6(3):
pubmed: 31167849
Cell Signal. 1997 May-Jun;9(3-4):237-48
pubmed: 9218123
J Neuroendocrinol. 1998 Oct;10(10):743-57
pubmed: 9792326
Results Probl Cell Differ. 2008;46:145-58
pubmed: 18204825
Neurosci Biobehav Rev. 2017 May;76(Pt A):87-98
pubmed: 28434591
Neuron. 2008 Jul 10;59(1):11-34
pubmed: 18614026
J Comp Neurol. 2000 May 8;420(3):305-23
pubmed: 10754504
Clin Neuropharmacol. 1996 Oct;19(5):451-6
pubmed: 8889289
Synapse. 2017 Apr;71(4):
pubmed: 27997737
Biochem Soc Trans. 2013 Feb 1;41(1):180-4
pubmed: 23356280
Neuron. 2017 Mar 22;93(6):1464-1479.e5
pubmed: 28334609
Brain Struct Funct. 2017 Mar;222(2):1007-1026
pubmed: 27376372
J Comp Neurol. 1985 Nov 15;241(3):275-84
pubmed: 2868027
Handb Exp Pharmacol. 2018;248:435-471
pubmed: 29374836
Neuron. 2017 Jan 4;93(1):164-178
pubmed: 28017470
Mol Pain. 2007 Jun 05;3:13
pubmed: 17550594
Neurosci Biobehav Rev. 1997 Sep;21(5):649-78
pubmed: 9353797
Front Neurosci. 2013 Aug 30;7:156
pubmed: 24009552
J Comp Neurol. 1988 Jul 8;273(2):149-62
pubmed: 3047185
Horm Behav. 2012 Mar;61(3):359-79
pubmed: 22245314
Mol Psychiatry. 2020 Feb;25(2):428-441
pubmed: 29904149
Eur J Neurosci. 2017 Sep;46(6):2149-2160
pubmed: 28833700
Nat Commun. 2017 Mar 22;8:14611
pubmed: 28327612
J Physiol. 2018 Dec;596(24):6289-6305
pubmed: 30281797
Nat Rev Neurosci. 2018 Aug;19(8):499-514
pubmed: 29934561
Pain. 2002 Mar;96(1-2):153-62
pubmed: 11932071
Pain. 2019 Jul;160(7):1614-1621
pubmed: 30870321
J Neurosci. 2018 Sep 5;38(36):7761-7773
pubmed: 30054393
J Neurosci. 2010 Apr 14;30(15):5451-64
pubmed: 20392966
Peptides. 2010 Oct;31(10):1878-83
pubmed: 20603169
Nat Neurosci. 2018 Jun;21(6):803-807
pubmed: 29786085
eNeuro. 2017 Mar 24;4(1):
pubmed: 28374004
Horm Behav. 2015 Nov;76:136-42
pubmed: 25888455
Curr Opin Investig Drugs. 2010 Jan;11(1):63-71
pubmed: 20047160
Proc Natl Acad Sci U S A. 2010 Nov 9;107(45):19567-72
pubmed: 20974945
J Neurosci. 1995 Oct;15(10):6340-50
pubmed: 7472399
Front Neuroendocrinol. 2004 Sep-Dec;25(3-4):150-76
pubmed: 15589267
J Comp Neurol. 2006 Aug 20;497(6):910-27
pubmed: 16802333
Neurosci Lett. 1994 Apr 25;171(1-2):167-71
pubmed: 8084482
J Neurosci. 2015 Mar 18;35(11):4599-613
pubmed: 25788677
Mol Pain. 2014 May 29;10:32
pubmed: 24884567
Eur J Neurosci. 2014 Feb;39(3):455-66
pubmed: 24494685
J Neurosci. 2017 Feb 8;37(6):1378-1393
pubmed: 28011743
Curr Top Behav Neurosci. 2018;35:193-211
pubmed: 28942595
Brain Res. 1986 Sep 24;382(2):213-38
pubmed: 2428439
Mol Pain. 2010 Sep 22;6:60
pubmed: 20860833
Neuroscientist. 2004 Jun;10(3):221-34
pubmed: 15155061
Regul Pept. 2009 Aug 7;156(1-3):90-5
pubmed: 19345242
Peptides. 2001 May;22(5):743-51
pubmed: 11337087
Neuropharmacology. 2016 Sep;108:284-91
pubmed: 27044664
Neuroscience. 2015 Sep 10;303:352-63
pubmed: 26164501
Neurosci Lett. 1992 Jan 6;134(2):243-6
pubmed: 1589151
Biol Psychiatry. 2010 May 1;67(9):831-9
pubmed: 20060104
Neurosci Lett. 1989 Jul 17;102(1):20-6
pubmed: 2550853
Neurosci Lett. 2004 May 6;361(1-3):254-7
pubmed: 15135941
Peptides. 1985 Jul-Aug;6(4):721-45
pubmed: 3906594
ACS Chem Neurosci. 2018 Sep 19;9(9):2252-2261
pubmed: 29630339
J Mol Psychiatry. 2013 Jun 05;1(1):9
pubmed: 25408902
J Comp Neurol. 2000 Dec 11;428(2):191-212
pubmed: 11064361
Curr Opin Neurobiol. 2018 Apr;49:141-147
pubmed: 29522976
Neurosci Lett. 1990 May 18;113(1):1-6
pubmed: 2366947
Neuron. 2015 Aug 5;87(3):605-20
pubmed: 26212712
Science. 2019 Jan 18;363(6424):276-281
pubmed: 30655440
J Neurosci. 2012 Jan 25;32(4):1488-95
pubmed: 22279233
Eur J Neurosci. 2012 Dec;36(11):3531-7
pubmed: 22928868
Pain. 2020 Mar;161(3):609-618
pubmed: 31725062
Endocrinology. 2006 Jul;147(7):3510-8
pubmed: 16574794
Biol Psychiatry. 2010 Sep 1;68(5):474-83
pubmed: 20705147
J Comp Neurol. 1997 Jul 7;383(3):305-25
pubmed: 9205043
J Neurophysiol. 2007 Jun;97(6):3893-904
pubmed: 17392412
Pain. 2019 Apr;160(4):824-832
pubmed: 30681985
Neuropharmacology. 2014 Feb;77:217-23
pubmed: 24107576
Eur J Neurosci. 2012 Nov;36(9):3204-13
pubmed: 22861166
Pharmacol Rev. 2008 Jun;60(2):143-5
pubmed: 18552275
Pain. 2017 Apr;158(4):543-559
pubmed: 28301400
Front Behav Neurosci. 2019 Jun 25;13:138
pubmed: 31293402
Curr Biol. 2007 Oct 23;17(20):R868-74
pubmed: 17956742
Front Neuroendocrinol. 2014 Apr;35(2):171-9
pubmed: 24145148
Front Neurosci. 2015 Dec 24;9:487
pubmed: 26733798
Behav Neurosci. 1992 Jun;106(3):518-28
pubmed: 1319714
Exp Neurol. 2011 Jul;230(1):96-105
pubmed: 21515261
J Histochem Cytochem. 1980 May;28(5):475-8
pubmed: 7381192
J Pharmacol Sci. 2009 Jan;109(1):33-7
pubmed: 19151539
J Physiol. 1993 Jan;460:705-18
pubmed: 8487215
eNeuro. 2018 Feb 6;5(1):
pubmed: 29445764
Neuroreport. 1997 Sep 8;8(13):2985-9
pubmed: 9376543
Med Res Rev. 2010 Sep;30(5):751-77
pubmed: 19824051
Mol Pain. 2017 Jan-Dec;13:1744806917709201
pubmed: 28604219
Curr Opin Pharmacol. 2002 Feb;2(1):23-33
pubmed: 11786305
CNS Neurosci Ther. 2016 Feb;22(2):102-17
pubmed: 26662472
J Pharmacol Exp Ther. 2015 Nov;355(2):206-11
pubmed: 26350161
J Neurosci. 2015 May 13;35(19):7317-25
pubmed: 25972162
Psychopharmacology (Berl). 2014 Jul;231(14):2751-8
pubmed: 24481567
Hum Brain Mapp. 2014 Feb;35(2):527-38
pubmed: 23097300
J Neurophysiol. 2003 Feb;89(2):716-27
pubmed: 12574449
Psychoneuroendocrinology. 2018 Jun;92:13-20
pubmed: 29609111
Nature. 2015 Jan 15;517(7534):284-92
pubmed: 25592533
J Comp Neurol. 2008 Feb 20;506(6):943-59
pubmed: 18085591
Curr Opin Support Palliat Care. 2015 Jun;9(2):131-7
pubmed: 25699686
Neuropsychopharmacology. 2005 Feb;30(2):223-30
pubmed: 15536493
Peptides. 2016 Aug;82:26-34
pubmed: 27224019
Pain. 2017 Apr;158(4):747-759
pubmed: 28225716
Neurosci Lett. 2019 May 29;702:15-23
pubmed: 30503916
J Neurophysiol. 2008 Mar;99(3):1201-12
pubmed: 18171711
Mol Pain. 2013 Feb 15;9:2
pubmed: 23410057
Alcohol Clin Exp Res. 2010 Jan;34(1):90-7
pubmed: 19860802
Mol Pain. 2010 Dec 16;6:93
pubmed: 21162731
Neuropsychopharmacology. 2016 Sep;41(10):2463-72
pubmed: 27013358
PLoS One. 2009 Dec 31;4(12):e8528
pubmed: 20052275
Neurogastroenterol Motil. 2005 Jun;17(3):415-22
pubmed: 15916629
Exp Neurol. 2017 Dec;298(Pt A):1-12
pubmed: 28830762
J Neurosci. 2003 Jan 1;23(1):52-63
pubmed: 12514201
Exp Physiol. 2002 Mar;87(2):251-8
pubmed: 11856971
Neuropsychopharmacology. 2012 Jun;37(7):1588-99
pubmed: 22298122
Neurosci Lett. 2018 Sep 25;684:187-192
pubmed: 30114475
Pain. 2017 Feb;158(2):296-305
pubmed: 27849648
Mol Pain. 2016 Nov 11;12:
pubmed: 27837170
Neuropharmacology. 2012 Apr;62(5-6):1999-2009
pubmed: 22248636
Curr Opin Support Palliat Care. 2014 Jun;8(2):143-51
pubmed: 24752199
Cephalalgia. 2017 Jul;37(8):780-794
pubmed: 28376659
Handb Exp Pharmacol. 2015;227:261-84
pubmed: 25846623
Brain Res. 1986 May 28;374(2):287-98
pubmed: 3013366
J Pharmacol Exp Ther. 2005 Feb;312(2):441-8
pubmed: 15388784
Pain. 2015 Sep;156(9):1803-11
pubmed: 26010460
Science. 2004 Mar 5;303(5663):1512-4
pubmed: 15001778
Int J Neuropsychopharmacol. 2012 Apr;15(3):375-87
pubmed: 21708052
J Pain Res. 2019 Mar 22;12:1069-1076
pubmed: 30962708
Brain Res Bull. 2001 May 1;55(1):117-21
pubmed: 11427346
Brain Res. 2004 Jan 2;995(1):23-8
pubmed: 14644467
Neuron. 2014 Jun 4;82(5):966-80
pubmed: 24908482
J Neurophysiol. 2006 Apr;95(4):2032-41
pubmed: 16306173
Neuropharmacology. 2012 Jan;62(1):398-405
pubmed: 21871467
J Pharmacol Exp Ther. 2013 Jul;346(1):130-7
pubmed: 23587526
J Comp Neurol. 2009 Jan 20;512(3):323-35
pubmed: 19003957
Pain Res Manag. 2017;2017:8296501
pubmed: 29302197
J Neurosci. 2003 Jan 15;23(2):700-7
pubmed: 12533630
J Pain. 2010 Dec;11(12):1461-71
pubmed: 20624690
Neuropsychopharmacology. 2012 May;37(6):1323-37
pubmed: 22278093
Front Neuroendocrinol. 2016 Jan;40:1-23
pubmed: 25951955
Cell Rep. 2019 Oct 8;29(2):332-346.e5
pubmed: 31597095
J Comp Neurol. 2011 Jul 1;519(10):1867-93
pubmed: 21452235
Neuropharmacology. 2017 May 1;117:124-133
pubmed: 28163104
J Neurophysiol. 2002 Jan;87(1):103-12
pubmed: 11784733
Pain. 2013 Aug;154(8):1325-32
pubmed: 23707306
J Neurosci. 2014 Feb 12;34(7):2432-7
pubmed: 24523533
Mol Pain. 2008 Jun 23;4:24
pubmed: 18573207
Front Neuroendocrinol. 1995 Oct;16(4):362-82
pubmed: 8557170
Trends Neurosci. 2018 May;41(5):280-293
pubmed: 29703377
J Comp Neurol. 2007 Oct 20;504(6):702-15
pubmed: 17722034
Am J Anat. 1982 Dec;165(4):385-96
pubmed: 6760710
Curr Mol Pharmacol. 2018;11(1):4-31
pubmed: 28260504
Mol Psychiatry. 2013 Dec;18(12):1273-80
pubmed: 23044705
Nature. 2010 Nov 11;468(7321):270-6
pubmed: 21068836
Neuroscience. 2007 Sep 7;148(3):737-43
pubmed: 17706366
Eur J Neurosci. 2002 Jan;15(2):384-8
pubmed: 11849304
Brain Res. 2006 Feb 9;1072(1):46-54
pubmed: 16423327
J Comp Neurol. 1999 Oct 11;413(1):113-28
pubmed: 10464374
Curr Protein Pept Sci. 2013 Aug;14(5):407-15
pubmed: 23745704
Neuropharmacology. 2014 Feb;77:294-302
pubmed: 24157490
Brain Struct Funct. 2019 Apr;224(3):1067-1095
pubmed: 30610368
Int J Mol Sci. 2019 Sep 06;20(18):
pubmed: 31489921
Pain. 2017 Dec;158(12):2386-2395
pubmed: 28832395
Science. 1981 Sep 18;213(4514):1394-7
pubmed: 6267699
Neuropharmacology. 2010 Jan;58(1):29-34
pubmed: 19523478
Trends Pharmacol Sci. 2002 Feb;23(2):71-7
pubmed: 11830263
J Neurophysiol. 1992 Aug;68(2):551-69
pubmed: 1527575
Transl Psychiatry. 2015 Mar 03;5:e517
pubmed: 25734510
Neuropharmacology. 2017 Oct;125:418-428
pubmed: 28807676

Auteurs

Volker Neugebauer (V)

Department of Pharmacology and Neuroscience, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA; Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, TX, USA; Garrison Institute on Aging, Texas Tech University Health Sciences Center, Lubbock, TX, USA. Electronic address: volker.neugebauer@ttuhsc.edu.

Mariacristina Mazzitelli (M)

Department of Pharmacology and Neuroscience, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Bryce Cragg (B)

Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA.

Guangchen Ji (G)

Department of Pharmacology and Neuroscience, School of Medicine, Texas Tech University Health Sciences Center, Lubbock, TX, USA; Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Sciences Center, Lubbock, TX, USA.

Edita Navratilova (E)

Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.

Frank Porreca (F)

Department of Pharmacology, College of Medicine, University of Arizona, Tucson, AZ, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH